Pharmaceutical Value-added Processes from a Regional Hub in Panama
Serving the Latin American market can be a challenge facing
many pharmaceutical companies. Aside
from traditional supply chain targets, such as quicker response to the market, quality
control, temperature and cold-chain management during warehousing and transit,
we will approach one specific question; how do we assure regulatory compliance,
specially, without hindering production in our manufacturing sites?
Flexibility is a key word when evaluating logistic services
in Latin America. A key goal in the
supply chain of the pharmaceutical industry is to assure manufacturing sites
are solely focused in producing, meanwhile getting products into markets as
soon as demand is created, while complying with all regulations.
Panamá, the “Hub of the Americas”, offers an ideal solution
to companies searching for answers of the above questions. With special economic areas in both the
Atlantic (Colón Free Trade Zone) and Pacific (Panamá Pacífico) oceans, great
connectivity, fiscal incentives, ease of doing business, among many other
benefits, value-added services and flexibility is as key as all of the
above. We will focus the following on
understanding the benefits of a value-added operation from Panama.
Imagine a scenario where your manufacturing site has to
assure regulatory compliance before shipping out to Honduras, Colombia, Costa
Rica, or any other market in Latin America.
Without current existence of uniformity and joint regulation in the
region, it is a big challenge. This
might affect production since artwork, working capital, regulatory affairs
amongst other must all be aligned for production. This also increases to the challenge, that
once the product complies with a specific market, you must ship out and
commercialize within it. Lead times from
manufacturing sites to distributors can extended to 60-90 days and the risk or
product expiration also increases drastically.
As mentioned at the beginning, in todays competitive market, it is key
to assure that manufacturing sites are lean and dedicating solely to
production.
A hub for Latin America in Panama solves many of these
issues. First of all, manufacturing
sites only have to assure production is carried out. Products can be shipped bulk or with standard
artwork, simplifying and making manufacturing sites leaner. Another important benefit is that once
products arrive into the Hub, inventory is flexible to any market. If demand projections are not accurate, one
market over sales, another one undersells, all inventory is still regional, and
not market specific as in the previous scenario. Once demand is “hard” or confirmed, a
value-adding site allows the flexibility to modify any pharmaceutical
packaging. This leads us into the detail
of possibilities in the value-added process which includes traditional work
such as “ink-jet printing” of regulatory information (registration number,
institutional sales, samples etc.). Other
types of jobs include secondary packaging, leaflets and special commercial
packaging for consumer goods. All of
these carried out in a GMP, regulated and audited environment. Maybe the best part of this being, that the
turnaround time from product reception into the Panama Hub, value-added
process, and exporting can be a 24-48 hour cycle time. With daily flights from Panama into all major
Latin American cities, customers can have products in destination 48-72 hours
after product ships into your hub.
The future most likely will keep evolving as the current
model brings so many benefits it is possible to take even more advantage from
it. We will possibly be looking at
companies evaluating bulk packaging and transport from manufacturing sites to a
repackaging site in the region and doing all secondary/tertiary packaging from
the regional hub. This allows even more
productivity and lean-manufacturing, even more inventory flexibility, and
passing challenges and regulatory variability of the region even more so
directly to the market. This can be
achieved while still having more competitive lead-times to the distribution
network due to Panama´s excellent connectivity.
It will be very interesting to see the evolution of this process within
the next five to ten years.
Subscribe to:
Post Comments (Atom)
Powered by Blogger.
After i personal been visitors the actual utilizes such as this sort of very careful number can be correct shining. Someone perspective unsurprisingly elaborated the actual guidelines related to salubrious spectacle arrangement featuring produce full can be grab. Respect an individual because of this. mail boxes panama
ReplyDeletehello!! Very interesting discussion glad that I came across such informative post. Keep up the good work friend. Glad to be part of your net community. modafinil Nederland
ReplyDeletePharmaceutical Manufacturing has provided peak of success to the world of medicines and Pharmaceutical engineering. It basically deals with the development of active medicines that can fight against dreadful diseases such as sexually transmitted diseases, cardiovascular problems, reproductive disorders, various infectious diseases. pharmaceutical consulting
ReplyDeletearket. If demand projections are not accurate, one market over sales, another one undersells, all inventory is still regional, and not market specific as in the previous scenario. Once demand is “hard” or confirmed, a value-adding site allows the flexibility to moBuy Percocet Online
ReplyDeleteOn the off chance that an individual is stalled out with Arthritis, he should take joint inflammation pharmaceuticals items, which are assisting patients with getting eased from the intense torment of this illness. tadalafil powder manufacturer
ReplyDeleteThis comment has been removed by the author.
ReplyDeleteSimilarly as with vehicle tints, private window film arrives in different tones and gets done so you can totally tweak the appearance of your home while remembering your security needs.
ReplyDeleteKnoxville Window Tinting